Efficacy & Safety of Auto-FMT in Preventing aGVHD

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05643638` - A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD	Phase 2
Recruiting	`NCT03214289` - Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host Disease	Phase 1
Completed	`NCT04038827` - Origin of CEC in Patients After Allo-HSCT
Recruiting	`NCT05362630` - Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study

See also

Status

Clinical Trial

Phase

Recruiting

NCT05643638 - A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD

Phase 2

Recruiting

NCT03214289 - Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host Disease

Phase 1

Completed

NCT04038827 - Origin of CEC in Patients After Allo-HSCT

Recruiting

NCT05362630 - Infliximab Efficacy, TDM and Serum TNFα Levels in Pediatric HSCT Recipients With aGVHD: Prospective Observational Study

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04745221
Study type	Interventional
Source	The First Affiliated Hospital of Soochow University
Contact
Status	Recruiting
Phase	N/A
Start date	March 1, 2021
Completion date	March 1, 2026

Efficacy and Safety of Auto-FMT in Preventing aGVHD

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms